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Several lines ofevidence indicate that glia play an important role in supporting
the growth of neurons (1-7). Using peripheral nerve grafts, Aguayo et al. (1)
have shown that neurons of the mammalian central nervous system (CNS)' are
capable of dramatic axonal sprouting when they are in a suitable glial environ-
ment. By altering glial cell populations in developing and regenerating neural
systems in vivo, other investigators (3, 4) confirmed that glia were necessary for
successful neuronal migration or axonal growth. In vitro studies extend these
observations by suggesting that glia secrete growth regulating factors (4, 5) or
produce extracellular matrix proteins that influence neuronal growth (1, 6-8).
Thus, an understanding of events that mediate glial cell growth may help to
elucidate the mechanisms that control neuronal development and recovery from
CNS injury (8-9).
Recently, lymphokines and monokines found in the CNS havebeen implicated
as regulators ofglial cell growth and proliferation (10-12). IL-1 has been isolated
from the brain of rats following injury (10), and cultured brain cells have been
found to secrete factors in vitro similar to IL-1 (12). IL-1 is a peptide growth
factor released by many cell types, but particularly by activated mononuclear
phagocytes in response to endotoxin or following phagocytosis of bacteria or
inert particles such as silica (13). IL-1 is thought to mediate tissue damage during
inflammation by stimulating Tcell function (14), by inducing prostaglandin and
protease release (15), and by stimulating fibroblast proliferation (16). Since IL-1
has been isolated from traumatized mammalian brain and shown to be a potent
astroglial growth factor, we have proposed (10) that IL-I may regulate astroglial
proliferation at the site of CNS injury.
The cellular sources of brain II-1 remain uncertain. Although blood mono-
cytes enter the brain after certain types of trauma (17-19), cells intrinsic to the
brain have also been implicated as a source ofthe IL-1 . Fontana et al. (12), for
example, report that enriched populations of astroglia release IL-1 in culture.
Alternatively, ameboid microglia, mononuclear phagocytic cells of the brain,
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have also been shown (20) to release peptide factors that stimulate glial growth .
Using newly developed methods to separate astroglia from ameboid microglia
(21), we examined specific glial populations for their abilities to secrete IL-1 . We
report here that ameboid microglia, when activated, release significant quantities
of IL-l .
Materials and Methods
Enriched Astroglial Cell Cultures.
￿
Astroglia prepared by the method of McCarthy and
de Vellis (22, 23) were grown on glass coverslips in 35-mm culture dishes (10). Indirect
immunofluorescence techniques were used to identify astroglia as those cells bearing glial
fibrillary acidic protein (GFAP), and oligodendroglia as those cells bearing galactocere-
broside (GC) (21-24). Enriched astroglial cultures, treated with 5 MM L-leucine methyl
ester (25) for 3 h at 37°C to eliminate contaminating microglia (20, 26) contained >98%
fibroblast-like astroglia. These cultures, grown in 1 .5 ml defined medium (27), were
incubated with partially purified IL-1 from rat microglia (1 .5% by vol) for 72 h. The
proliferation of astroglia was determined by counting cells in 10 randomly selected fields
(0.314 mm2) in at least three cultures for each experimental group. Astroglial number in
cultures incubated for 72 h with IL-I or column fractions was expressed as fold increase
over that in control cultures that received PBS in volumes equivalent to those of the
factors added to treated cultures. Under these conditions, control astroglial cell number
increased by 150-250% over a 5-d period (22). Astroglial proliferation was also measured
by incorporation of [sH]thymidine into cells grown in 96-well microtiter plates (30,000
cells/well) containing 200 ul of defined culture medium and IL-1 . After incubation for
60 h, 1 uCi of [3H]thymidine (sp. act., 2 .0 mCi/mmole) (Amersham Corp., Arlington
Heights, IL) was added to each well for an additional 12 h . Quantitation of incorporated
radioactivity was determined by scintillation counting of well contents harvested onto
glass filter strips.
Enriched Microglial Cell Cultures. We have recently (21) described the isolation of
ameboid microglia from the brain of newborn animals. Ameboid microglia were obtained
(20, 21) from mixed glial cell cultures grown for 1 wk in plastic flasks containing defined
medium with 10% FCS. The flasks of 1-wk-old mixed glial cells were agitated for 15 h on
a rotary shaker (180 rpm) at 37°C, and the cells suspended by agitation were transferred
to plastic flasks. Ameboid microglia selectively adhered to plastic within 2 h at 37° C in
defined medium containing 10% FCS (23). Adherent cells were resuspended in a
Ca"/Mg"-free PBS with 5 mM EDTA, and transferred to a plastic flask containing
defined medium with 10% FCS. The cells adhering after a second 2-h period consisted
of 95 ± 3% nonspecific esterase-positive (26) ameboid microglia and contained the
acetylated low-density lipoprotein receptor. The probe for acetylated low-density lipopro-
tein (LDL), fluorescent diocytadecyl-3,3,3',3'-tetramethyl carbinocyanine (Dil-ac-LDL)
(28) was a gift from Dr. David Via of the Department of Medicine, Baylor College of
Medicine.
We have, in a recent report (21), compared the properties of microglia with those of
monocytes and macrophage of newborn rat. All three cell types were phagocytic cells that
expressed the acetylated low-density lipoprotein receptor, as well as the macrophage
antigens MAGI and MAC-3 (19-21, 26). Ameboid microglia couldbe distinguished from
monocytes and macrophages by a lack of peroxidase activity at the time of initial plating
of dissociated brain cells (21). Moreover, ameboid microglia proliferated in vitro and
incorporated [sH]thymidine, while under identical culture conditions, monocytes and
macrophages did not increase in cell number or show significant thymidine incorporation.
And finally, ameboid microglia, when incubated with retinoic acid, grew out processes
several hundred microns in length (21). Based upon such observations, we believe that
ameboid microglia are a class of phagocytic cell that may be distinguished from blood
monocytes and spleen macrophage (21).
Identification and Isolation of IL-1.
￿
IL-1 activity was assayed as incorporation of
['H]thymidine by mouse thymocytes (29) and by the D-10 cell line assay (30). IL-1 activity
was expressed as U/ml according to the procedure of Schmitt and Ballet (31). Antibody596
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neutralization of microglial IL-1 was performed with anti-murine IL-1 by Dr. Mitchell
Dukovich in the laboratory of Dr. Steven Mizel at Bowman Gray School of Medicine (32).
This IgG fraction isolated from goat serum was produced against purified murine IL-1,
and has been extensively characterized. The fraction specifically neutralizes murine IL-1,
has been used for affinity purification of IL-1 (32), and has been used to recover
recombinant murine IL-1 (36).
Suspensions of fixed Staphylococcus aureus, 20 ul of washed bacteria per 1 .5 ml of
culture medium (Calbiochem-Behring, San Diego, CA); LPS, 5 ug/ml (from Escherichia
coh ; Sigma Chemical Co., St. Louis, MO); or recombinant murine IFN-f 100 U/ml
(provided by Dr. Isaiah J. Fidler, M . D. Anderson Hospital), were tested for their abilities
to stimulate IL-I release from microglia and astroglia.
The isolation of brain IL-1 was performed by previously described methods (10, 29).
Gel filtration chromatography was performed using a calibrated 100 x 0.9-cm P10 (Bio-
Rad Laboratories, Richmond, CA) column in PBS (10). Bioassays were carried out on
fractions ranging from 3 kD to those found in the void peak, with an exclusion size of
^-20 kD. 50 ml of macrophage- or microglia-conditioned defined medium were concen-
trated by ultrafiltration using a YM-2 membrane (Amicon Corp., Danvers, MA), and the
sample was clarified by filtration through a 0.45-um membrane filter (Acrodisc; Gelman
Sciences, Ann Arbor, MI). A 1 .0-ml sample containing 10 mg of protein was applied to
the P10 column and 0.7-ml fractions were collected. Anion-exchange chromatography
was performed using a Waters Model 720 HPLC apparatus and a TSK-5PW (0.75 x 7.5-
mm) DEAE column (Bio-Rad Laboratories) (29). The chromatography was performed in
2.0 mM Tris buffer (pH 8.0), and the IL-1 activity was eluted by a gradient of 0.00-0.5
M sodium acetate, in 2.0 mM Tris (pH 8.0) .
Results
Cellular Sources of Brain IL-1.
￿
We wished to determine whether IL-1 was
released into the culture medium conditioned by specific populations of glial
cells. Initial studies using mixed cultures of astroglia and microglia, in serum-
free medium, showed that small quantities of IL-I-like activity could be detected
in the medium by 48 h. To monitor the capacity of astroglia and microglia to
secrete IL-I, it was first necessary to isolate these cells from the brain ofnewborn
rats. Ameboid microglial preparations (Fig. IA), obtained as described in Mate-
rials and Methods, were a homogeneous population with nearly all cells showing
receptors for acetylated LDL (Fig. 1 B). Ameboid cells were readily distinguished
from astroglia by phase-contrast microscopy and a lack of GFAP (Fig. 1) . Using
the methods of McCarthy and de Vellis (23), we obtained astroglial preparations
with >90% GFAP+ cells, which also contained -5% ameboid microglia. These
ameboid cells could be eliminated from astroglial preparations by exposure to
the lysosomotrophic agent L-leucine methyl ester (Fig. 1, E and F) (20) .
To test the ability of ameboid microglia and astroglia to release IL-I, culture
dishes containing 150,000 ameboid microglia or astrocytes were stimulated with
either LPS, fixed S. aureus, IFN-y, or PBS. As shown in Fig. 2, microglia
responded to 5 ag/ml of LPS or 20 ul of suspended fixed S. aureus with the
release of 11 .0 ± 1 .0 and 13 .3 ± 0.8 U of IL-1 activity per 1,000 microglial
cells, respectively. Similar doses of LPS and S. aureus resulted in 1 .5 ± 0.5 and
1 .4 ± 0 .2 U, respectively, of IL-1 per 1,000 astroglia. IFN-y failed to stimulate
IL-1 release from either cell type.
Biochemical and Immunological Characterization ofMicroglial IL-1.
￿
To confirm
that the thymocyte-stimulating activity released by microglia was in fact IL-1,
several different experiments were performed on serum-free medium condi-
tioned by cultured ameboid microglia . 50-ml samples of IL-1 activity preparedGIULIAN ET AL .
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FIGURE 1 .
￿
Photomicrographs of enriched preparations of ameboid microglia and astroglia
isolated from newborn rat brains . A : Phase-contrast micrograph of ameboid microglia isolated
from mixed glial cultures by selective adhesion (see Materials and Methods) . B: Nearly all of
the isolated ameboid microglia express the acetylated LDL receptor, as shown by the fluores-
cent probe diocytadecyl-3,3,3',3'-tetramethyl carbinocyanine (Dil-ac-LDL) . C: Phase-contrast
photomicrograph of ameboid microglia after staining with GFAP . D : Fluorescence photomi-
crograph shows that ameboid microglia from C lack the astroglia-specific antigen, GFAP . E:
Phase-contrast photomicrograph of enriched astroglia . F: Fluorescence photomicrograph
shows that the astroglial culture from E lacks Dil-ac-LDL-positive microglia . Bar = 20 jcm .
by culturing 7.5 x 106 microglia or 10 x 106 adherent peritoneal macrophages
with 0.5 ml of a S. aureus suspension for 48 h were concentrated by ultrafiltration
andfractionated by gelfiltration chromatography using a P-10 column . Asshown
in Fig. 3, the activated microglia released an 18 kD factor that stimulated [3H]-598 INTERLEUKIN 1 FROM AMEBOID MICROGLIA
Astroglia
￿
Microglia
FIGURE 2.
￿
Release of IL-1 by enriched glial cultures. Astroglia and microglia (^-150,000
cells/culture) were incubated for 48 h in the presence of PBS (20Al/culture), fixed S. aureus,
LIPS, or IFN-f to induce IL-1 release (see Materialsand Methods). Theconditioned medium
was examined for IL-1 activity by the mouse thymocyte assay. IL-1 activity represents mean
values ±SE obtained from at least five cultures per experimental group, and are expressed as
U/10"cells.
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FIGURE 3.
￿
Gel filtration chromatography of culture medium from activated microglia. IL-1
activity wasdetermined in triplicate for each fraction in the murine thymocyte assay (top) and
the D-10 cell line assay for IL-I (bottom). A single peak of activity of -18 kD was found to
stimulate[sH]thymidine incorporation. Molecular mass markers: A, 16.9 kD; B, 8.5 kD; C, 6.2
kD. The void peak did not contain biologic activity.
thymidine incorporation in murine thymocytes (Fig. 3, top) and in the IL-1-
sensitive D10 cell line (Fig. 3, bottom). Medium conditioned by rat peritoneal
macrophage produced IL-1 activity that eluted in an identical fashion (data not
shown) . The 18-20 kD fractions secreted by microglia and macrophages were
further characterized by DEAE-anion-exchange HPLC. The IL-1 activity in
both samples was found to elute at the same sodium acetate molarity (Fig. 4).
In addition to copurification, we examined microglial IL-1 by antibody neu-
tralization. Antisera to murine IL-1 and human IL-1 were tested for the ability
to inhibit rat microglial IL-1 stimulation of thymocyte incorporation of
['H]thymidine. An antibody to human IL-1-/3 was unable to neutralize the rath
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FIGURE 4.
￿
Anion-exchange chromatography ofthe 18 kD IL-I activities released by activated
microglia and macrophages. 2-ml samples from the peaks of IL-1 activity (Fig. 3) were
fractionated by HPLC using a DEAE column and an increasing sodium acetate gradient (see
Materials and Methods). Each fraction wasassayed in triplicate for IL-1 activity in the murine
thymocyte assay. Coelution was found for IL-1 obtained from both cellular sources.
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FIGURE 5. Inhibition of microglial IL-1 by antiserum to murine IL-1 . Microglial IL-I
containing 90 U/ml was diluted over a range from 1 :80 to 1:640. To each dilution, goat anti-
murine IL-1 serum was added, and the cultures were incubated at 37°C for 18 h. IL-1-
responsive murine thymocytes were added to each dilution, and the inhibition of IL-I activity
was calculated as a percentage of control culture without antibody (31).
microglial IL-I (data not shown), nor did it inactivate rat macrophage IL-I, an
observation previously reported (30). As shown in Fig. 5, antibody to murine IL-
I was able to neutralize the biological activity of rat microglial IL-I and of rat600
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FIGURE 6 .
￿
Photomicrographs of enriched astroglial cultures after treatment with rat micro-
glial IL-I . Cultures were treated for 3 d with either PBS (A and B) or 5% (by vol) of the 18
kD gel chromatography-purified IL-1 (C and D) . As shown by immunofluorescence staining
for GFAP, IL-1 markedly increased the number ofastroglia (D) .
macrophage IL-1 (30), suggesting that microglial IL-1 sharesacommon antigenic
site with IL-1 released from rat peritoneal macrophage .
IL-1 and Astroglial Growth .
￿
We have previously shown the ability of human
IL-1 to stimulate the growth of rat astrocytes in mixed glial cell cultures (10) .
To confirm that rat microglial IL-1 could also stimulate the growth of rat
astrocytes, rat microglial IL-1 purified by gel filtration chromatography was
added to enriched astroglial populations . As shown in Fig . 6, there was a five- to
sevenfold increase in the number of GFAP+ astroglia after a 72-h incubation
with microglial IL-1 . We also observed a three- to fivefold increase in [3H]-
thymidine incorporation by enriched astroglial cultures (Fig . 7) . Microglial IL-1O _J K) O O S 00 -
Z
6
Z Q
0 ~- n 4
2
r
F-
GIULIAN ET AL.
￿
601
2.0%
￿
2.0% 1.0% 0.1%
OIL-1
CONTROL
VOLUME ADDED
FIGURE 7.
￿
Incorporation of['H]thymidine by astroglia stimulated with gel chromatography-
purified rat microglial IL-1 . 3.0 x 10' cells were grown in the presence of IL-1 for 72 h and
incubated with 1 PCi [sH]thymidine for the final 12 h before harvesting.
therefore increases the number of astroglia by accelerating the proliferation of
mature GFAP+ astroglia in vitro.
Discussion
Astroglia proliferate in the brain during embryonic development and after
injury. Specific peptide growth factors have been isolated from the brain during
these periods (10, 22), and have been implicated as regulators ofgliogenesis (33).
In this report, we show that one factor released by ameboid microglia is an 18
kD peptide that stimulates the growth of astroglia. By using copurification
techniques, antibody neutralization, and two different types of IL-1 assays, we
have shown that this factor is IL-1 . Secondly, we have shown microglial IL-1
stimulates astroglial proliferation in vitro. The effect of IL-1 upon astroglia is,
moreover, further supported by recent work in our laboratory showing that
recombinant IL-I is a mitogen for both brain astroglia and the astrocytoma cell
line, U373 (unpublished data).
Microglia are probably not the only source of IL-1 within the CNS. For
example, blood monocytes entering the brain after penetration injuries might
also secrete IL-I (18). Moreover, Fontana et al. (12) have shown that enriched
cultures of astrocytes, as well as astroglial cell lines, are able to produce IL-1 .
We find that astroglial cultures can be stimulated to release IL-1, albeit in small
quantities (Fig. 2). Our cultures of astroglia were treated with leucine methyl
ester to eliminate microglia as a possible source of IL-1 . In this way, by deter-
mining more accurately the level of IL-1 production by astroglia, we concluded
that ameboid microglia are the major producers of brain IL-1 in vitro.
Although both astroglia and ameboid microglia might release IL-I in vivo, we
propose that ameboid cells are the more likely source of IL-1 during acute phases
of brain injury. In general, astroglial scar formation is a later event in brain
injury, one that follows microglial invasion of damaged tissue (17, 18). Since
microglia are the first brain cells to appear in increased numbers at sites of
trauma or infections, we suggest that IL-1 released from these ameboid cells
stimulates the proliferation of neighboring astroglia (20) . In a similar way, other602
￿
INTERLEUKIN I FROM AMEBOID MICROGLIA
investigators have suggested that macrophages control wound repair by release
of IL-I to promote fibroblast proliferation (16).
Caution should, of course, be observed when attempting to relate in vitro
findings to the in vivo actions of brain IL-1. The ability ofany growth factor to
influence cell proliferation in vivo depends upon notonly the densityofsecretory
cells, but also the availability of factor-sensitive target cells. Further work is
needed to delineate IL-I sensitivities of the various cell populations found within
intact brain. The control ofIL-1 secretion is also important when examining the
role of IL-1 in vivo. Although microorganisms might stimulate IL-1 release from
microglia during infection, the actual regulators of IL-I secretion within the
brain are unknown. Identification of such microglial activators will help to
elucidate initial events regulating inflammation within the CNS.
The brain contains growth factors that stimulate astroglial proliferation during
development and in response to injury (9, 20, 33). It is conceivable that devel-
opmental growth factors (33) and inflammatory factors found in the brain (21)
are structurally similar. For example, fibroblast growth factor (FGF) isolated
from brain has recently (34) been found to have a significant sequence homology
with IL-1. Although FGF does not stimulate proliferation ofmouse thymocytes
or DIO cells (34), both FGF and IL-I stimulate the growth ofastrocytes (33, 35).
Further study to determine the cellular source ofbrain FGF, and in particular
its relationship to ameboid microglia, will be of interest.
Finally, if glia do, in fact, mediate neuronal development and axonal growth,
then factors that control glial outgrowth or reduce glial scarring might be
revealed from IL-1-related research. As a potent immunomodulator, IL-I now
represents another link between the immune system and the nervous system.
Furthermore, since IL-I release isaconvenient andsensitive marker ofmicroglial
activation, measurement of IL-1 levels may prove useful in monitoring degen-
erative or inflammatory diseases of the CNS.
Summary
By screening specific populations of rat brain cells, we found that ameboid
microglia secrete an 18 kD peptide with IL-1 biological activity. The IL-1 activity
released by microglia was found to be identical to rat macrophage IL-1 on
fractionation by gel filtration and high pressure liquid anion-exchange chroma-
tography, and it was neutralized by an antiserum specific for murine IL-1. When
added to astroglia grown in culture, microglial IL-1 increased the cell number
of five- to sevenfold, and increased astroglial incorporation of [3H]thymidine by
three- to fivefold. We propose that the proliferation ofastroglia in specific brain
regionsmay be regulated by the signaled release ofIL-1 from activated microglial
cells.
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